Cytosorbents Corp. buy Quitte
Start price
28.01.20
/
50%
€5.11
Target price
04.11.21
-
Performance (%)
8.91%
End price
05.11.21
€5.56
Summary
This prediction ended on 05.11.21 with a price of €5.56. With a performance of 8.91%, the BUY prediction by Quitte for Cytosorbents Corp. closed with a slight gain. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cytosorbents Corp. | -1.295% | -1.295% | -65.046% | -90.078% |
| iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
| iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
| iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
| iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
Comments by Quitte for this prediction
In the thread Cytosorbents Corp. diskutieren
Buy Cytosorbents Corp.
Corona lässt grüßen ;-)
Cytosorbents latest entry in coronavirus rally; shares up 17% premarket
Jan. 28, 2020 8:06 AM ET|About: Cytosorbents Corporation (CTSO)|By: Douglas W. House, SA News Editor
Thinly traded micro cap Cytosorbents (NASDAQ:CTSO) is up 17% premarket on average volume on the heels of the publication of a report in The Lancet detailing the clinical features of patients in Wuhan, China infected with the coronavirus 2019-nCoV. The company says levels of circulating inflammatory cytokines are correlated with the severity of illness, providing the rationale for using blood purifier CytoSorb to reduce cytokine levels and ameliorate inflammation.
In the thread Trading Cytosorbents Corp.
Die von Quitte gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Quitte for Cytosorbents Corp.
Cytosorbents Corp.
Start price
Target price
Perf. (%)
€9.12
06.11.18
06.11.18
€16.24
06.05.19
06.05.19
-24.33%
06.05.19
06.05.19
Cytosorbents Corp.
Start price
Target price
Perf. (%)
€5.14
22.12.16
22.12.16
€6.48
22.06.17
22.06.17
-23.68%
22.06.17
22.06.17